Recent advances in genome databases have allowed discovery of novel classes of natural products and their biosynthetic enzymes. Given the potentials and advantages of the biosynthetic enzymes, they are applicable to not only the production of natural products but also synthesis and discovery of artificial molecules with desired functions. This account describes our recent efforts to develop artificial in vitro biosynthesis systems that potentially allow for the elaboration of pseudo-natural peptides with novel bioactivities.
No takes yet. Share an insight, caveat, or question.
Goto et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: